Veristat Strengthens Regulatory Capabilities Across Europe and UK
Acquires Drug Development and Regulation (DDR), a regulatory consultancy led by former senior officer at European Medicines Agency (EMA)
Veristat Appoints Colleen Pelton Chief Talent Officer
Global Talent Executive to Advance Company’s Commitment to a Best-in-class Workforce
Veristat Announces New Investment Partner—WindRose Health Investors
Recapitalization Will Accelerate Strategic Growth to Help Sponsors Save and Improve the Lives of Patients
Veristat Congratulates Origin Biosciences for FDA Approval
Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare Disease Day 2021
Veristat Expands Biometrics Capabilities by Acquiring SQN Clinical
Builds on a shared pedigree of data management, statistics and programming excellence across all phases of clinical trials
SOUTHBOROUGH, MA...
Veristat Supported Marketing Applications for 10% of all FDA Novel Drug Approvals in 2020
Strengthening its Track Record of Successful Client Regulatory Approval Outcomes
SOUTHBOROUGH, MA – January 14, 2021 – Veristat, a...
Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice...
Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe
Veristat Named a Top Patient Recruitment Company by PharmaTech Outlook
Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials
SOUTHBOROUGH, MA – December 7, 2020 –Veristat, a...